Serum procalcitonin as a biomarker differentiating delayed-type drug hypersensitivity from systemic bacterial infection
[...]the diagnosis of drug hypersensitivity is clinical and is a diagnosis of exclusion, because laboratory measurements are rarely helpful to diagnose it. [...]the levels of serum procalcitonin may be a better biomarker than serum CRP levels for distinguishing delayed-type drug hypersensitivity fro...
Saved in:
Published in | Journal of allergy and clinical immunology Vol. 132; no. 4; pp. 981 - 983 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Mosby, Inc
01.10.2013
Elsevier Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | [...]the diagnosis of drug hypersensitivity is clinical and is a diagnosis of exclusion, because laboratory measurements are rarely helpful to diagnose it. [...]the levels of serum procalcitonin may be a better biomarker than serum CRP levels for distinguishing delayed-type drug hypersensitivity from systemic bacterial infection. |
---|---|
Bibliography: | SourceType-Other Sources-1 ObjectType-Article-1 content type line 63 ObjectType-Correspondence-2 |
ISSN: | 0091-6749 1097-6825 |
DOI: | 10.1016/j.jaci.2013.04.038 |